The House Energy and Commerce Subcommittee on Oversight and Investigations holds a hearing on e-cigarette use in the United States amid an ongoing youth tobacco epidemic and one day before the US Food and Drug Administration (FDA) is set to begin enforcement of the agency’s weak guidance released in early January that put industry profits above the health of children.
Cancer patients, survivors and caregivers will tune into the president’s State of the Union address tonight, watching to see if the president will commit to improving the nation’s health care system by preserving access to comprehensive and affordable health care coverage.
Today the Centers for Medicare and Medicaid Services (CMS) announced guidance that would fundamentally alter the Medicaid program.
Washington, D.C. – January 23, 2020 – A report on smoking cessation released today by United States Surgeon General Jerome M.
Patient and health advocacy groups representing millions of Americans with pre-existing conditions are disappointed over the U.S. Supreme Court’s decision today not to immediately take up the case of Texas v. United States.
Patient and health advocacy groups representing millions of Americans with pre-existing conditions filed an amicus curiae or friend of the court brief today urging the U.S. Supreme Court to immediately take up the case of Texas v. United States. The case is the latest court challenge to the health care law known as the Affordable Care Act.
Washington, D.C. – January 2, 2020 – The U.S.
Washington, D.C. –U.S. Rep. John Lewis recently announced he has been diagnosed with stage IV pancreatic cancer. A statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN) follows:
The U.S. House will vote today on a bill intended to bring down patient prescription drug costs. Several of the bill’s provisions are important to cancer care, including establishing an annual cap on Medicare enrollees’ out-of-pocket expenses, allowing some Medicare beneficiaries to spread out high-cost prescription cost-sharing over the course of the year, and expanding Medicare eligibility for low-income subsidies.
Washington, D.C. Mi– Today the US Senate voted to confirm Dr. Stephen Hahn as the next commissioner of the Food and Drug Administration (FDA).
Following is a statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN):